Massart P, Bèzes H
Br J Clin Pharmacol. 1986;22 Suppl 2(Suppl 2):161S-165S. doi: 10.1111/j.1365-2125.1986.tb02999.x.
1 A 10 day double-blind study was carried out comparing isoxicam (300 mg day-1) and piroxicam (40 mg day-1 for the first two days and 20 mg day-1 for the remaining days) following surgery in patients who had sustained skiing accidents. There were 20 patients in each group. The isoxicam-treated group had a slightly greater mean pain score prior to treatment. 2 Both isoxicam and piroxicam reduced pain and nocturnal awakening at days 5 and 10, but isoxicam was significantly superior to piroxicam in producing improvement in pain (at day 5, P less than 0.05) and in nocturnal awakenings (at day 10, P less than 0.05). 3 Both agents facilitated rehabilitation and there was no significant difference between them in this regard. 4 All patients in both groups considered themselves 'better' or 'much better' on day 5 of treatment. 5 Both agents were well tolerated by most patients but one patient in each group left the trial because of abdominal pain. One patient stopped isoxicam when she was found to be pregnant.
对遭受滑雪事故的患者术后进行了一项为期10天的双盲研究,比较异丁苯丙酸(300毫克/天)和吡罗昔康(头两天40毫克/天,其余几天20毫克/天)的疗效。每组有20名患者。异丁苯丙酸治疗组在治疗前的平均疼痛评分略高。
异丁苯丙酸和吡罗昔康在第5天和第10天均减轻了疼痛和夜间觉醒,但异丁苯丙酸在改善疼痛方面(第5天,P<0.05)和夜间觉醒方面(第10天,P<0.05)显著优于吡罗昔康。
两种药物均促进了康复,在这方面两者之间无显著差异。
两组中的所有患者在治疗第5天时都认为自己“好转”或“大有好转”。
大多数患者对两种药物耐受性良好,但每组各有一名患者因腹痛退出试验。一名患者在被发现怀孕后停用了异丁苯丙酸。